Ampio Pharmaceuticals News
The companys stock price has collected 2372 of gains in the last five trading sessions. Research Shows Ampion Gene Regulation Mimics the Anti-Inflammatory Effects of Steroids. Ampio Pharma Shares Plunge 71 After Bad News From Fda Biospace All patients in the study. Ampio pharmaceuticals news . AMEXAMPE went up by 321 from its latest closing price compared to the recent 1-year high of 298. Ampio Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for prevalent inflammatory conditions for which limited treatment options exist. NYSEAMPE shares rose in value on Wednesday Apr 28 with the stock price up by 259 to the previous days close as strong demand from buyers drove the stock to 198. AMPE announced today that it received FDA approval of the Companys special protocol assessment SPA of a clinical protocol titled A Randomized Controlled Double-Blind Study to Evaluate the Efficacy and Safety of an Intra-Articular Injection of Ampion in Adults wi